Chevy Chase Trust’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Chevy Chase Trust's XBI Position: Q3 2021 in Review
Chevy Chase Trust sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2021, closing a stake of 1,500 shares — an estimated $203K sold.
Chevy Chase Trust first reported a position in XBI in Q2 2013 and held it in 24 quarters. The position peaked at $7M in Q4 2013. 635 funds tracked by Wall St. Rank hold XBI as of Q3 2021.
- Chevy Chase Trust reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2021 after selling out during the quarter.
- Chevy Chase Trust sold 1,500 State Street SPDR S&P Biotech ETF shares in Q3 2021, an estimated $203K.
- Chevy Chase Trust first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 24 quarters.
- Chevy Chase Trust's State Street SPDR S&P Biotech ETF position peaked at $7M in Q4 2013.
- 635 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2021.
Based on Chevy Chase Trust's 13F filing for Q3 2021, filed 20 Oct 2021.